FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation
PMA: P220032
·
Supplement: S010
·
Decision Mar 21, 2025
Classifications
1
FEI Numbers
61
Registration Numbers
61
Basic Information
- Device Name
- Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation
- Trade Name
- Boston Scientific Cardiac Cryoablation System
- PMA Number
- P220032
- Supplement Number
- S010
- Device Class
- FDA Class 3
- Product Code
- OAE
- Generic Name
- Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- March 21, 2025
- Date Received
- February 21, 2025
- Supplement Type
- Special (Immediate Track)
- Supplement Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Expedited Review
- N
Advisory Committee Statement
approval for modifications to the device labeling, including additional warnings and recommendations regarding esophageal protection
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| OAE | Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation | FDA class 3 | Unknown |